Mirova US LLC Grows Position in Intuitive Surgical, Inc. $ISRG

Mirova US LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 47.8% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 568,123 shares of the medical equipment provider’s stock after purchasing an additional 183,631 shares during the quarter. Intuitive Surgical makes up approximately 3.2% of Mirova US LLC’s portfolio, making the stock its 11th biggest position. Mirova US LLC’s holdings in Intuitive Surgical were worth $308,724,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ISRG. Brighton Jones LLC boosted its stake in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. NBC Securities Inc. bought a new position in shares of Intuitive Surgical during the first quarter valued at approximately $135,000. Miracle Mile Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.8% during the first quarter. Miracle Mile Advisors LLC now owns 1,983 shares of the medical equipment provider’s stock valued at $982,000 after acquiring an additional 35 shares in the last quarter. Capital Investment Advisors LLC raised its holdings in shares of Intuitive Surgical by 179.0% during the first quarter. Capital Investment Advisors LLC now owns 2,508 shares of the medical equipment provider’s stock valued at $1,242,000 after acquiring an additional 1,609 shares in the last quarter. Finally, Wesbanco Bank Inc. raised its holdings in shares of Intuitive Surgical by 23.8% during the first quarter. Wesbanco Bank Inc. now owns 1,505 shares of the medical equipment provider’s stock valued at $745,000 after acquiring an additional 289 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 1.9%

ISRG opened at $440.94 on Wednesday. The stock has a fifty day simple moving average of $461.55 and a two-hundred day simple moving average of $499.41. The company has a market cap of $158.07 billion, a price-to-earnings ratio of 61.50, a price-to-earnings-growth ratio of 4.71 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.78 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. BTIG Research restated a “buy” rating and set a $571.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 1st. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Truist Financial upped their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Wells Fargo & Company upped their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a report on Wednesday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $589.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.